RadioBDC Logo
Stolen Dance | Milky Chance Listen Live
THIS STORY HAS BEEN FORMATTED FOR EASY PRINTING

Drug may cut cardiac risks

By Deborah Kotz
Globe Staff / November 14, 2011

E-mail this article

Invalid E-mail address
Invalid E-mail address

Sending your article

Your article has been sent.

Text size +

In a finding that could alter treatment for heart patients, those who took the anti-clotting drug rivaroxaban daily after a heart attack or life-threatening chest pain had a lower risk of dying or suffering another heart attack than patients who took a placebo.

For more from BostonGlobe.com, sign up or log in below

To continue, please sign up or log in to BostonGlobe.com

Access the full articles and quality reporting of The Boston Globe at BostonGlobe.com

Sign up

Unlimited Access to BostonGlobe.com for 4 weeks for only 99¢.

Are you a Boston Globe home delivery subscriber?

Get FREE access as part of your print subscription.

BostonGlobe.com subscriber

Click to continue reading this article or to log in to BostonGlobe.com.